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Background and aims: Parasitic infections, especially opportunistic parasites, can cause serious 
problems for immunocompromised patients. In this regard, this study aimed to evaluate parasitic 
infections in cancer patients undergoing chemotherapy after referring to Kashani hospital of Shahrekord 
from January to May 2018.
Methods: In this cross-sectional descriptive study, 750 stool samples were collected from 250 cancer 
patients undergoing chemotherapy (three fecal samples from each patient) and sent to the Parasitology 
Laboratory of Shahrekord University of Medical Sciences. All samples were examined macroscopically 
and microscopically through the direct method and a specific acid-fast staining method. To confirm the 
microscopic results, DNA was extracted from isolated parasites and amplification was performed by 
the polymerase chain reaction with the specific primers on positive samples. 
Results: In this study, 106 (42.4%) and 144 (57.6%) patients were males and females, respectively. 
In addition, 187 (74.8%) and 63 (25.2%) of them were living in urban and rural areas, respectively. 
In terms of the education level, most patients had a low level of literacy. Further, 12 (4.8%) patients 
were infected with intestinal parasites that including, 7 (2.8%), and 5 (2%) samples were infected with 
Blastocystis hominis and Giardia lamblia, respectively.
Conclusion: The results of this study showed that B. hominis and G. lamblia are the most prevalent 
parasites in cancer patients undergoing chemotherapy. Although the prevalence of intestinal parasites 
in cancer patients was low, these findings should not be contrary to the need for healthcare regarding 
the prevention of parasitic infections in cancer patients.
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One of the most important general public health 
indicators of any community is the status of its infectious 
diseases including parasitic (i.e., protozoan and helminth) 
infections.1,2 Protozoan infections cause global problems 
such as barriers to social and economic development, 
particularly in developing countries.3 Therefore, the 
efficient control of parasitic infections can be an advantage 
of the health and economy of countries.4 Despite persistent 
efforts and the extensive planning of the World Health 
Organization (WHO), they are still one of the major 
health problems in developing countries.3 According to the 
WHO report, the number of people who are chronically 
infected with different types of parasites in worldwide 
is estimated to be approximately 3 billion persons.5,6 
In addition, it seems that the probability of infection is 
high by various types of microorganisms (e.g., parasites, 
fungi, bacteria, and viruses) in immunocompromised 
persons such as cancer patients due to the involvement of 
lymphocytes and the degradation of the immune system 
of the body. The infection of immunocompromised 
patients with these microorganisms can be a major cause 
of morbidity and mortality in these groups.7 The diagnosis 
of infection in these patients is often difficult according 
to the typical symptoms of infection (e.g., fever) and 
remains hidden or absent due to a decrease in white blood 
cells, thus it is highly necessary to identify infections 
in this group of patients.8,9 On the other hand, the 
number of immunocompromised patients is increasing 
gradually in the world due to an increase in the number 
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of cancer patients and the progress of cancer diagnosis 
methods, followed by treatment with chemical drugs, 
radiation and organ transplants in different wards of the 
hospital.10 Regarding the limited number of studies on 
the parasitic infection in immunocompromised patients 
in Chaharmahal va Bakhtiari province, it is necessary to 
investigate the frequency of protozoan parasitic infections 
in cancer patients undergoing chemotherapy. Nonetheless, 
given the importance of the timely diagnosis of parasitic 
infections in these patients and their critical need for 
treatment against these infections, limited studies are 
available in this regard. It is noteworthy that using 
diagnostic methods for the parasitic disease is attractive 
and effective because of features such as the lack of a need 
for expensive and complicated equipment, high sensitivity 
and specificity, and the speed in obtaining the results. 
Accordingly, this study aimed to evaluate the frequency 
of intestinal protozoa in cancer patients in Shahrekord in 
2018.
Materials and Methods 
In this descriptive cross-sectional study, data were 
collected through observation, interviews and recorded 
in demographic forms for each patient. The required 
data such as individual characteristics were extracted 
from information forms and the results were evaluated 
and reported accordingly. The study population included 
cancer patients undergoing chemotherapy who referred to 
the Kashani hospital of Shahrekord, which is the capital of 
Chaharmahal va Bakhtiari province located in the central 
southwest of Iran.
Number and Method of Sampling
Census and non-probabilistic sampling methods were 
used in this study. Approximately, 90-100 cancer 
patients are admitted to the oncology ward of Kashani 
hospital every month. Therefore, sampling was done 
on 250 cancer patients who were admitted under the 
chemotherapy process for 1 month to more than 37 
months during January-May 2018 and were willing to 
participate in the study. Before starting the procedure, 
permission was obtained from the Ethics Committee 
and hospital authorities. A questionnaire was prepared, 
containing information such as age, gender, type of job, 
and level of education. After questionnaire completion, 
three stool collection containers labeled with the name or 
number of the patient were given to each subject. Then, 
the samples were quickly transported to the Department 
of Parasitology and Mycology, the School of Medicine, 




The most commonly performed procedure in parasitology 
is the observation and identification of trophozoites, cysts, 
and oocysts of protozoa and ova, along with the larva and 
the segment of helminths by the wet mount technique. 
The physiological serum was used to prepare wet slides. 
Accordingly, the name and number of the patient were 
written on one side of the slide using a diamond pen, 
and then a drop of physiological serum was placed on the 
slide. Using a wooden applicator, a small portion of the 
sample (about 2 mg) was removed and gently mixed with 
the physiology serum. Furthermore, the lamellae (22 × 22 
mm) were gently placed on the sample and the droplet 
mixture so that the lamellae edge was in contact with the 
droplet and prevented bubble formation. For microscopic 
observations, the entire surface of the slide was regularly 
examined from one corner upward, downward, backward, 
and forward at ×100 magnification. In the case of 
suspected cases, ×400 magnification and appropriate light 
were utilized for the exact detection of trophozoites and 
the cysts of protozoa, as well as the eggs and larvae of 
helminths.7
Cold Ziehl Neelsen Method
The alkaline fuchsine stain includes two strains (A and B) 
that are prepared as follows.
To prepare solutions A and B, 0.3 g of the fuchsine 
stain and 5 g of phenol crystals were dissolved in 10 
mL of 95% ethanol and 100 mL of distilled water and 
then heated, respectively. Next, solution B was added 
to solution A. It should be noted that this stain is stable 
for 1 year at room temperature. In this study, 1 mL of 
hydrochloric acid was added to 99 mL of methanol at 
95%. To prepare the background stain, 0.3 g of methylene 
blue was dissolved in 100 mL of distilled water. Moreover, 
the physiologic serum was used to prepare smear from 
consistent samples. The smears were prepared in such 
a way that newspaper inscriptions were readable after 
drying. The prepared smears were then air-dried, and 
absolute methanol was applied to stabilize the sample in 
staining stages.7 Additionally, the smear prepared from the 
stool sample was dried. To stabilize the smear, it was fixed 
for 3 minutes using methanol, and the surface of the smear 
was covered with carbol fuchsin for 20 minutes. Next, the 
smeared surface was washed with water. Further, staining 
was performed 1 to 10 second(s) using 1% chloric acid 
bleach and then the surface was re-washed with water. In 
addition, the smeared surface was stained and re-washed 
using the 0.3% methylene blue solution for 30 seconds. 
Eventually, the smear was air-dried and then examined by 
light microscopy at ×100 and ×400 magnifications and 
using the impression oil at ×1000 magnification.8
Polymerase Chain Reaction 
To confirm the obtained results by microscopy, 
samples that were positive for intestinal protozoa were 
tested on positive samples by the polymerase chain 
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reaction (PCR) and nested PCR for B. hominis and G. 
lamblia, respectively, in the parasitology laboratory of 
Shahrekord University of Medical Sciences. Next, DNA 
was extracted from stool samples using the Qiagen 
kit (QIAamp® DNA Stool (50541)) according to the 
manufacturer’s instructions. For purity and qualify, 
DNA was surveyed by a NanoDrop device (Thermo 
Scientific, Lithuania). Then, microscopic results were 
confirmed using specific primers, namely, forward primer 
3’-ATCTGGTTGATCCTGCCAGT-5’-and reverse 
primer 3’-GAGCTTTTTAACTGCAACAACG-5 of B. 
hominis designated by Pandey et al9 and the outer forward 
primer (AL3543) 3’-AAATIATGCCTGCTCGTCG-5’ 
and the outer reverse primer (AL3546) 3’- 
CAAACCTTITCCGCAAACC-5’ and the inner forward 
primer (AL3544) 3’-CCCTTCATCGGIGGTAACTT-5’, 
and the inner reverse primer (AL3545) 
3’-GTGGCCACCACICCCGGGGGGGGGGGGGGG 
of G. lamblia. The primers were used for the nested PCR 
primers described by Sulaiman et al.11
The PCR for B. hominis was performed and a 600 bp 
fragment amplified the SSU rDNA gene. Moreover, PCR 
was performed in a 20 μL mixture containing the template 
4 μL of DNA, 0.5 μL of each primer (10 pmol/μL), 5 μL 
distilled water, and 10 μL of the master mix (Ampliqone, 
Denmark). The PCR conditions consisted of one cycle 
denaturing at 95°C for 5 minutes, 35 cycles including 
denaturing at 95°C for 20 seconds, extending at 58°C 
for 20 seconds, annealing at 72°C for 20 seconds, and an 
additional cycle with a 5-minute chain elongation at 72°C. 
The nested PCR for G. lamblia was done with the 
production of a 530 bp fragment amplified of the TPI 
gene for two steps. This work was conducted in a 20 μL 
mixture containing the template 2 μL of DNA (2.5 μL 
in the second stage), 0.5 μL of each primer (10 pmol/
μL), 7 μL distilled water (6.5 μL in the second stage), and 
10 μL of the master mix (Ampliqon, Denmark). After 
initial denaturation at 94°C for 5 minutes, each of the 
cycles consisted of denaturation at 95°C for 45 seconds, 
annealing at 50°C for 50 seconds, and extension at 72°C 
for 1 minute for 35 cycles, and final extension was done at 
72°C for 10 minutes. Finally, the PCR product was stained 
with power load and electrophoresed on a 1.5% gel, and 
then was visualized on a UV-Transilluminator by the gel 
documentation system. 
Data Analysis Method
The results of each individual’s test were recorded in a 
questionnaire. Eventually, SPSS 16 software and chi-
square and Fisher exact tests were used for extracting data 
and performing statistical tests. In this survey, P < 0.05 was 
considered statistically significant.
Results 
In this study, 250 cancer patients within the age range of 
4-85 years with a mean of 49.1 years (SD = 20.09) suffering 
from different cancer types (Figure 1) were evaluated in 
terms of intestinal parasitic infections. Table 1 presents 
demographic data including gender, living place, age, job, 
education level, and the duration of chemotherapy.
In the present study, 7 (2.8%) and 5 (2%) samples out of 
250 cancer patients were infected with B. hominis and G. 
lamblia, respectively. These parasites were detected in the 
group of patients with acute lymphocytic leukemia (n=5, 
41.8%), digestive (n=2, 16.7%), chronic lymphocytic 
leukemia (n=1, 8.3%), lung (n=1, 8.3%), bladder (n=1, 
8.3%), stomach (n=1, 8.3%), and breast cancer (n=1, 
8.3%). It is noteworthy that all clients were sampled three 
times, and all samples were examined in duplicate. In 
addition to the direct method, all samples were examined 
using modified Ziehl Neelsen staining. The results of 
this study showed that 100% of the stained samples were 
negative in terms of the presence of Coccidia oocysts, and 
the concentration of the extracted DNA was surveyed 
with a NanoDrop device in terms of quantity, purity, and 
quantity prepared for the PCR reaction optical density 
(OD) : 1.75). 
Primers AL3543 and AL3546, as well as AL3544 and 
AL3545, were used to confirm G. lamblia infection. All 
samples of the patients infected by G. lamblia in the direct 
assay were confirmed by the PCR, and the results indicated 
that they were also positive in the molecular method 
(Figure 2).
Additionally, the single-step PCR through RD5 and 
BhRDr primers was used to determine the B. hominis 
genus. In addition, all samples of patients infected with B. 
hominis were examined by PCR methods for final approval 
of this parasite (Figure 3).
Similarly, all samples of patients infected with G. lamblia 
and B. hominis were examined by PCR methods regarding 
the final approval of these parasites.
Figure 1. Evaluation of Cancer Type in Cancer Patients Undergoing 
Chemotherapy Referring to Ayatollah Kashani Hospital in 
Shahrekord in 2018.
Note. AML: Acute myeloid leukemia; CLL: Chronic lymphocytic 
leukemia; ALL: Acute lymphocytic leukemia.
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The statistical analyses of results indicated that there 
were no significant relationships between gender, age, 
living place, job, education level, and intestinal parasites 
in cancer patients undergoing chemotherapy (P>0.05) 
although intestinal parasitic infection in these patients 
was significantly related to the duration of chemotherapy 
(P < 0.05).
Discussion 
Cancer is one of the highly severe diseases of humans that 
have a major socioeconomic impact on societies worldwide. 
More than half of all cancers occur in developing countries 
such as those located in South America and Asia, and 
nearly three-quarters of these people live in low- and 
middle-income countries. Further, the rate of cancer 
survivors in developing countries is often one-third of 
those living in developed countries.12,13 Annually, 9 million 
new cancer cases are reported across the world, including 
4 and 5 million in developed and developing countries, 
respectively. Furthermore, more than 1.2 million 
Americans are affected by cancer each year, and more 
than 56 000 of them die due to malignancy in the United 
States. It is predicted that a higher percentage of deaths in 
the world will be caused by non-communicable diseases in 
the near future and cancer will account for about 13% of 
all deaths. It is also predicted that cancer will be the first 
and the leading cause of human death by 2030.10,14 The 
most common cancers in the world are lung, stomach, and 
breast, respectively. Moreover, the most prevalent types in 
Iran are skin, breast (in women), gastric and prostate (in 
Table 1. The Prevalence of Intestinal Parasites Based on Demographic Characteristics in Cancer Patients Referring to Ayatollah Kashani Hospital in Shahrekord in 
2018
Variable No. (%) Infected No. (%) Non-infected No. (%) P Value
Gender
Male 106 (42.4) 7 (6.6) 99 (93.4)
0.198
Female 144 (57.6) 5 (3.5) 139 (96.5)
Living place
Urban 187 (74.8) 7 (3.7) 180 (96.3)
0.148
Rural 63 (25.2) 5 (7.9) 58 (92.1)
Age groups (year)
<10 17 (6.8) 1 (5.9) 16 (94.1)
0.982
11-20 12 (4.8) 1 (8.3) 11 (91.7)
21-30 14 (5.6) 1 (7.14) 13 (92.86)
31-40 27 (10.8) 1 (3.7) 26 (96.3)
41-50 49 (19.6) 3 (6.1) 46 (93.9)
51-60 55 (22) 2 (3.6) 53 (96.4))
60 ˂ 76 (30.4) 3 (3.9) 73 (96.1)
Job
Farmer 12 (4.8) 2(16.6) 10 (83.4)
0.130
Ranchman 10 (4) 0 10 (100)
Employee 14 (5.6) 0 14 (100)
Self-employed 55 (22) 1 (1.8) 54 (98.2)
Housewives 116 (46.4) 2 (1.72) 114 (98.3)
Unemployed 27 (10.8) 5 (20.8) 22 (79.2)
Retired 16 (6.4) 2 (12.5) 14 (87.5)
Education level
Illiterate 87 (34.8) 1 (1.15) 86 (98.85)
0.227*
Elementary 60 (24) 7 (11.7) 53 (88.3)
Secondary 31 (12.4) 1 (3.2) 30 (96.8)
High school 41 (16.4) 1 (2.4) 40 (97.6)
Academic 31 (12.4) 2 (6.5) 29 (93.5)
Duration of chemotherapy (months)
1-6 162 (64.8) 7 (4.3) 155 (95.7)
0.027
7-12 27 (10.8) 2 (7.4) 25 (92.6)
13-24 29 (11.6) 0 29 (100)
25-36 17 (6.8) 2 (11.8) 15 (88.2)
Over 37 15 (6) 1 (6.7) 14 (93.3)
Macroscopic results of stool samples 
(consistency)
Formed 147 (58.8) 8 (5.4) 139 (94.6)
0.946
Soft 74 (29.6) 3 (6.4) 71 (93.6)
Loose 23 (9.2) 1 (4.3) 22 (95.7)
Watery 6 (2.4) 0 6 (100)
Note. *P < 0.05 represents a statistically significant difference.
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men), bladder, colorectal and esophageal cancers.10,13,15
Chemotherapy, radiotherapy, immunotherapy, and 
surgery are therapeutic interventions in the cancer 
treatment that have helped increase the life expectancy of 
cancer patients and, in some cases, have led to complete 
remission.16 One of the main agents in the pathogenesis, 
progress, and treatment of different cancers is the status of 
the immunity system of patients.10 The immune system of 
cancer patients is suppressed by a variety of factors 
including cancer itself (especially, the malignancies of B 
and T lymphocytes), spreading of malignant cells into 
other tissues such as bone marrow, high-dose 
chemotherapeutic agents, and corticosteroids.12 The 
suppression immunity of humans by different agents such 
as chemotherapeutic drugs is placing the person at the risk 
of infection by a wide variety of opportunistic agents such 
as parasites that may cause a potentially lethal disease in 
this population.13 Opportunistic parasitic infections 
including worms and protozoa cause mild or asymptomatic 
diseases in immunocompetent people although they can 
cause fatal diseases in immunocompromised patients. 
Additionally, immunosuppression in cancer patients, 
which is due to chemotherapy, may trigger latent intestinal 
parasitic infections. Therefore, parasitic infections are one 
of the common health problems in cancer patients.14 
Various studies have focused on the prevalence of parasitic 
infections in cancer patients, indicating different results 
affected by some factors such as the number of patients, 
the type of malignancy, the immu nocompromising effects 
of the chemotherapy, the geographical climate status of the 
study area, the socioeconomic and hygiene status of a 
society, and the use of differ ent diagnostic methods with 
different sensitivity levels.17-20 Based on the findings of 
epidemiological studies on cancer patients for assaying 
intestinal parasitic infections, the rate of these infections 
varies from 12.9% to 88.9% in different areas of the 
world.13,16,17,19-23 Various reports are available regarding the 
prevalence of intestinal infections among 
immunocompromised people in Iran while information 
about these infections on cancer patients is rare in 
comparison with other immunocompromised groups such 
as human immunodeficiency virus/acquired 
immunodeficiency syndrome (HIV/AIDS), organ 
transplant, and hemodialysis patients. However, the results 
of several studies conducted in Iran showed that the 
prevalence of intestinal parasite infections among cancer 
patients under chemotherapy varies from 4.16% to 
35.9%.5,18,24-29 On the other hand, the current widespread 
use of chemotherapy has altered the pattern of some 
parasitic infections so as they have become one of the most 
important causes of the global risk of health and probably 
the cause of an increase in the rate of morbidity and 
mortality in immunocompromised patients.30,31 This cross-
sectional descriptive study assessed the epidemiological 
state of intestinal parasitic infections among cancer patients 
undergoing chemotherapy in Shahrekord, Iran. The results 
of our study demonstrated that 12 (4.8%) out of 250 
cancer patients were infected by two common protozoans, 
including 7 (2.8%) and 5 (2%) patients who were infected 
with B. hominis and G. lamblia, respectively. Similarly, the 
prevalence of intestinal parasitic infections in cancer 
patients was reported as 4.16% in Guilan (Northeast 
Iran),18 6.7% in Kashan and Qom (Central Iran),28 10% in 
Ardabil (Northwestern Iran) 5, 24.8% in Isfahan (western 
Iran),26 16.3% in Hamaden (Southwest Iran),29 19.8% in 
Urmia (Northwest Iran),32 25.9% in Tehran (Northwestern 
Iran),27 and 35.9% in Mashhad (Northeast Iran).24 The 
Figure 2. Electrophoresis Results of the Specific PCR Products of the 
Direct Smear Samples of Giardia lamblia Positive Samples in a 1.5% 
Agarose Gel.
Note. PCR: Polymerase chain reaction. M: 100 bp marker (Column 
6: Negative control; Column 1: positive control; Columns 2-5: 
Patients’ sample 530 bp, 6: Negative control).
Figure 3. Electrophoresis Result of the Specific PCR Products of the 
Direct Smear Samples of Blastocystis hominis Positive Samples in a 
1.5% Agarose Gel.
Note. PCR: Polymerase chain reaction. M: 100 bp marker (Column 
1: negative control; Column 2: Positive control; Columns 3-6: 
Patients’ sample 600 bp).
                                                                                                          Int J Epidemiol Res, Volume 7, Issue 4, 2020   149
Banihashemi et al
findings of some of these investigations are in line with our 
results while those of some other studies contradict our 
findings. In this regard, studies conducted in different 
areas of the world demonstrated variable results. For 
instance, Menon et al. showed that 42% of children with 
different types of cancer in Malaysia were infected with 
intestinal parasites.21 In addition, Jeske et al reported that 
61.6% of cancer patients undergoing chemotherapy in the 
south of Brazil were infected with intestinal parasites.23 
Another study conducted in India revealed that 16.5% of 
1029 cancer patients were infected with intestinal 
parasites.20 Likewise, Botero et al concluded that 32.4% of 
immunocompromised patients with and without 
gastrointestinal manifestations in Colombia, including 
individuals with acute lymphoid leukaemia, chronic 
myeloid leukaemia, HIV, and other immunocompromised 
conditions (principally haematological disorders), were 
infected with these parasites.33 Concerning the relationship 
between parasitic infections and cancer or diseases with 
immune system deficiency, it is hypothesized that parasitic 
infections are highly prevalent in cancer patients and those 
undergoing chemotherapy. Several studies have shown 
that the prevalence of intestinal parasites in cancer patients 
taking immunosuppressive drugs is higher compared to 
healthy control groups.34,35 In a study conducted by 
Monsef et al, the prevalence of intestinal parasites in 
patients with malignancy was lower than that of the 
general population, which may be due to the effect of the 
applied drugs in chemotherapy.29 On the other hand, the 
results of some studies indicated that the prevalence of 
parasitic infections in these patients was not significantly 
different compared to other healthy people. For instance, 
Salehi et al. found that despite the reducing effect of 
chemotherapy-related drugs on the immune system, they 
may have a destructive effect on parasitic cells and reduce 
the parasites in these individuals as well. Furthermore, risk 
factors for the acquisition of parasitic infections are the 
same in both immunocompetent and immunosuppressed 
individuals although cancer patients may be less exposed 
to parasitic agents due to intensive care. Additionally, 
those undergoing chemotherapy may be less exposed to 
parasitic infections due to decreased activity and increased 
health care.25 Environmental, exogenous, and endogenous 
factors, as well as individual factors, including genetic 
predisposition contribute to the creation and development 
of cancer. Therefore, people’s occupation is one of the 
external environmental factors that can cause cancer.36 The 
results of the present study showed that the rate of 
intestinal parasitic infections was higher in housewives in 
comparison with other jobs. This is mainly because most 
housewives are involved in cleaning, cooking, washing 
vegetables and fruits, shopping, and the like. Hence, 
exposure can be an important factor in parasitic infection. 
Moreover, Azizi et al investigated the relationship between 
parasitic infections and cancer and found the highest rate 
of infection in housewives.26 In the present study, the 
majority of infected patients were either illiterate or had an 
elementary level of education. This is in conformity with 
the results of other studies and is scientifically justified 
because people with low levels of education are more prone 
to various infectious and parasitic diseases due to the lack 
of knowledge about the methods of transmission and the 
lack of receiving necessary health educations. In another 
study, Niazi et al evaluated the prevalence of giardiasis 
among the staff of food processing and distribution centers 
in the economic zone of Pars-e Jonubi (South pars). 
According to their results, the highest parasitic infection 
was observed in people with a lower level of education 
compared to other groups.37 Although cancer patients 
could be infected with different parasites, epidemiological 
studies on cancer patients indicated that most prevalent 
parasites were B. hominis and G. lamblia among these 
patients, which is consistent with the results of our study. 
In this regard, assessing the frequency of the intestinal 
parasites between children with lymphohematopoietic 
malignancy in Mashhad, Zabolinejad et al reported G. 
lamblia (18%), Entamoeba coli (6.7%), and B. hominis 
(5.6%) as the most prevalent parasites.24 Additionally, 
Esteghamati et al detected intestinal parasites in cancer, 
organ transplant, and primary immunodeficiency patients 
in Tehran. According to their results, B. hominis (22.3%) 
was the predominant intestinal parasitic infection in 
cancer patients, followed by G. lamblia (2.3%) and 
Dientamoeba fragilis (1.1%).27 B. hominis is a highly 
common infection that is not usually diagnosable by 
conventional laboratory methods. In addition, the 
reported prevalence of this parasite is less than its real rate. 
In a study conducted by Rahimi-Esboei et al, B. hominis 
was the most common parasitic infection in Mazandaran 
province (8.1%).38 Moreover, the infection by this parasite 
is widespread in other provinces of Iran.39 In a similar 
study by Amin et al in Mazandaran province, 44.68% of 
patients attending gastrointestinal clinics were infected 
with G. lamblia parasite, which was significantly higher 
than other infections.40 However, other studies reported 
that the G. lamblia was the most prevalent protozoan 
compared to other parasitic infections. In a systematic 
review and meta-analysis study by Abasian et al, the 
prevalence of G. lamblia was estimated to be 14.7% (1.48-
39.54%) in Iran, including 15.1%, 19.2%, and 6.7% 
among children under 10 years old, adolescents, and  20-
30 year old adults,41 which is consistent with the findings 
of studies conducted in western countries. The prevalence 
of G. lamblia in the study by Monsef et al was reported to 
be 5.8% in cancer patients,29 which is in line with the 
reported rate in this study. Cryptosporidium is one of the 
important opportunistic parasites with cosmopolitan 
distribution that can infect wide hosts. Although this 
protozoan in immunocompetent individuals causes acute 
self-limiting disease, in immunocompromised patients, it 
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can be a potentially life-threatening disease with severe and 
chronic diarrhea, and therefore, many epidemiological 
studies investigated cryptosporidium in 
immunocompromised persons.42 In this study, the samples 
of cancer patients were evaluated by the cold Ziehl Neelsen 
staining method but coccidian parasites were detected in 
any of the samples. By investigating the slides of stool 
samples by the hot acid-fast staining method, Salehi et al. 
reported that cancer patients in Tehran were not infected 
with Cryptosporidium spp. or Isospora belli. Contrarily, 
Berenji et al43 and Zabolinejad et al24 indicated that 
children with cancer undergoing chemotherapy in Tabriz 
and Mashhad were infected with Cryptosporidium spp.
Conclusion
The cancer patients, because of the immunosuppressive 
effect of chemotherapeutic agents, are potentially 
exposed to infection with different microorganisms such 
as opportunistic parasites. In this study, the prevalence 
of intestinal parasites in cancer patients undergoing 
chemotherapy was low and the detected parasites were B. 
hominis and G. lamblia. However, these findings should 
not be contrary to the need for healthcare to prevent 
opportunistic parasitic infections in cancer patients. In 
addition, the occurrence of opportunistic parasites such as 
Cryptosporidium spp. in immunosuppressed patients could 
be a potentially fatal risk. However, physicians should 
consider intestinal parasites as an important causative 
risk in cancer patients. Hence, it is advised to perform 
periodically screening for cancer patients in order to 
detect intestinal parasites by specific methods with high 
sensitivity such as PCR.
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